Page last updated: 2024-11-05

triazolam and Dementia Praecox

triazolam has been researched along with Dementia Praecox in 2 studies

Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.

Research Excerpts

ExcerptRelevanceReference
"Triazolam was administered to five psychiatric inpatients for a two-week period."2.66Behavioral side effects of triazolam in psychiatric inpatients: report of five cases. ( Bergiannaki, JD; Sakkas, PN; Soldatos, CR; Stefanis, CN, 1986)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arango, O1
Bielsa, O1
Grau, S1
Gelabert-Mas, A1
Soldatos, CR1
Sakkas, PN1
Bergiannaki, JD1
Stefanis, CN1

Trials

1 trial available for triazolam and Dementia Praecox

ArticleYear
Behavioral side effects of triazolam in psychiatric inpatients: report of five cases.
    Drug intelligence & clinical pharmacy, 1986, Volume: 20, Issue:4

    Topics: Adult; Clinical Trials as Topic; Depression; Double-Blind Method; Female; Hospitalization; Humans; M

1986

Other Studies

1 other study available for triazolam and Dementia Praecox

ArticleYear
Reversible azoospermia in a patient treated with triazolam.
    The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 1996, Volume: 1, Issue:3

    Topics: Adult; Antipsychotic Agents; Biperiden; Drug Monitoring; Drug Therapy, Combination; Humans; Hypnotic

1996